A phase II study of pomegranate extract for men with rising prostate-specific antigen following primary therapy.

被引:0
|
作者
Paller, C. J.
Ye, X.
Wozniak, P.
Gillespie, B.
Sieber, P.
Greengold, R.
Stockton, B.
Hertzman, B.
Efros, M.
Roper, R.
Liker, H.
Carducci, M. A.
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Adv Clin, Bannockburn, IL USA
[4] Pom Wonderful, Los Angeles, CA USA
[5] Urol Associates Lancaster Ltd, Lancaster, PA USA
[6] South Orange Cty Med Res Ctr, Laguna Hills, CA USA
[7] Lakeside Urol, St Joseph, MI USA
[8] Urol Grp, Cincinnati, OH USA
[9] Accumed Res Associates, Garden City, NY USA
[10] Urol Enterprises, Marietta, GA USA
[11] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
10.1200/jco.2011.29.15_suppl.4522
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4522
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer
    Smith, MR
    Kabbinavar, F
    Saad, F
    Hussain, A
    Gittelman, MC
    Bilhartz, DL
    Wynne, C
    Murray, R
    Zinner, NR
    Schulman, C
    Linnartz, R
    Zheng, M
    Goessl, C
    Hei, YL
    Small, EJ
    Cook, R
    Higano, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2918 - 2925
  • [22] Prostate Cancer Chemoprevention Study: An investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen
    Miyanaga, Naoto
    Akaza, Hideyuki
    Hinotsu, Shiro
    Fujioka, Tomoaki
    Naito, Seiji
    Namiki, Mikio
    Takahashi, Satoru
    Hirao, Yoshihiko
    Horie, Shigeo
    Tsukamoto, Taiji
    Mori, Mitsuru
    Tsuji, Hirokazu
    CANCER SCIENCE, 2012, 103 (01) : 125 - 130
  • [23] Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy
    Smith, MR
    Manola, J
    Kaufman, DS
    Oh, WK
    Bubley, GJ
    Kantoff, PW
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2723 - 2728
  • [24] Rising prostate-specific antigen after primary treatment of prostate cancer: Sequential hormone manipulation
    Schmid, Hans-Peter
    Keuler, Franz U.
    Altwein, Jens E.
    UROLOGIA INTERNATIONALIS, 2007, 79 (02) : 95 - 104
  • [25] Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy
    Slovin, SF
    Wilton, AS
    Heller, G
    Scher, HI
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8669 - 8673
  • [26] Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer
    Siemens, D. Robert
    Heaton, Jeremy P. W.
    Adams, Michael A.
    Kawakami, Jun
    Graham, Charles H.
    UROLOGY, 2009, 74 (04) : 878 - 883
  • [27] Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study
    Guess, BW
    Scholz, MC
    Strum, SB
    Lam, RY
    Johnson, HJ
    Jennrich, RI
    PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (04) : 301 - 304
  • [28] Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study
    B W Guess
    M C Scholz
    S B Strum
    R Y Lam
    H J Johnson
    R I Jennrich
    Prostate Cancer and Prostatic Diseases, 2003, 6 : 301 - 304
  • [29] Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy
    Smith, MR
    Manola, J
    Kaufman, DS
    George, D
    Oh, WK
    Mueller, E
    Slovin, S
    Spiegelman, B
    Small, E
    Kantoff, PW
    CANCER, 2004, 101 (07) : 1569 - 1574
  • [30] Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response
    Alexander, Brian M.
    Chen, Ming-Hui
    Carroll, Peter
    D'Amico, Anthony V.
    UROLOGY, 2007, 70 (02) : 320 - 323